Editas Medicine, Inc.
EDIT
$2.78
-$0.055-1.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -23.19% | -84.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.19% | -84.78% | |||
| Cost of Revenue | -39.15% | -45.29% | |||
| Gross Profit | 42.54% | -21.81% | |||
| SG&A Expenses | -3.86% | -18.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.34% | -38.48% | |||
| Operating Income | 27.89% | -2.76% | |||
| Income Before Tax | 30.03% | -67.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.03% | -67.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.03% | -67.61% | |||
| EBIT | 27.89% | -2.76% | |||
| EBITDA | 29.24% | -1.25% | |||
| EPS Basic | 31.15% | -66.72% | |||
| Normalized Basic EPS | 24.18% | -5.66% | |||
| EPS Diluted | 31.15% | -66.72% | |||
| Normalized Diluted EPS | 24.18% | -5.66% | |||
| Average Basic Shares Outstanding | 1.63% | 0.53% | |||
| Average Diluted Shares Outstanding | 1.63% | 0.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||